Pfizer's sales missed estimates for the quarter as the drugmaker tries to transition out of the pandemic. Pfizer chairman and CEO Albert Bourla discusses the path ahead for the company, including its plans for acquisitions. He speaks with Bloomberg Wall Street Week host David Westin.

Rep. of Guyana to the UN Carolyn Rodrigues Birkett Talks Her Bid For Secretary General
11:51

Pollster Frank Luntz Talks Midterms
11:34

Cuba Deputy FM De Cossio Talks US Sanctions Hobbling Cuban Economy
23:08